Related Experiment Video
Updated: Feb 27, 2026
05:30
Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
1.6K
Obesity and its implications on nononcological urological surgery
Andrea Mari1, Mohammad Abufaraj, Karim Mansy
1aDepartment of Urology, Medical University of Vienna, Vienna, Austria bDivision of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan cDepartment of Urology, University Medical Center, Rostock, Germany.
Current Opinion in Urology
|June 27, 2017
Summary
Obesity presents surgical challenges in urology, but evidence suggests many nononcological procedures are feasible and safe for obese patients. Success and complication rates are often comparable to nonobese individuals, though specific precautions may be needed.
Area of Science:
- Urology
- Surgical Oncology
- Obesity Medicine
Background:
- Obesity is increasingly prevalent in clinical practice.
- Obesity poses significant operative challenges and is associated with increased postoperative complications.
- Understanding the impact of obesity on nononcological urological surgery is crucial.
Purpose of the Study:
- To review and summarize the current literature on the implications of obesity in nononcological urological surgery.
- To assess the feasibility, safety, and outcomes of these procedures in obese patients.
Main Methods:
- Comprehensive literature search with an emphasis on publications from the last 18 months.
- Review and synthesis of existing studies on obesity and nononcological urological interventions.
Main Results:
- Data on incontinence surgery in obese patients are inconsistent, but success rates are high with low complication rates, comparable to nonobese women.
- Percutaneous nephrolithotomy and minipercutaneous nephrolithotomy are effective and well-tolerated in obese patients undergoing renal surgery.
- While specific precautions and instruments are necessary, evidence supports the feasibility and safety of various nononcological urological procedures in obese individuals.
Conclusions:
- Despite a lack of randomized clinical data and some inconsistent study results, evidence supports the feasibility and safety of nononcological urological interventions in obese patients.
- Success rates and overall complication rates in obese patients appear comparable to nonobese patients for many procedures, with notable exceptions.
- Further research is needed to solidify evidence, particularly through randomized clinical trials.
Related Concept Videos
01:21Drug Dosing: Obese Patients
315
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:25Urinary Tract Calculi VI: Surgical Management
672
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
672
01:21Inflammatory Bowel Disease V: Surgical Management
780
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
780